Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00321711
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2006-05-02
Brief Title:
Determination of Safe and Effective Dose of Romiplostim AMG 531 in Subjects With Myelodysplastic Syndrome MDSReceiving Hypomethylating Agents
Sponsor:
Amgen
Organization:
Amgen